CRISPR-Based Epigenome Editing is a targeted genome engineering technique that uses CRISPR-guided platforms to direct epigenetic modifiers to specific genomic loci, thereby enabling precise modification of epigenetic marks without altering the underlying DNA sequence.
49
Publications
8.7K
Citations
350
Authors
119
Institutions
Publications per year
2017–2026
41
Variants
Crispr Epigenome Editing
Parents
Publications
49
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
Aleksandar Vojta, Paula Dobrinić, Vanja Tadić et al. · Nucleic Acids Research · 2016 · 775 citations · Full text
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
James K. Nuñez, Chen Jin, Greg C. Pommier et al. · Cell · 2021 · 755 citations · Full text
1–5 of 49
Authors
350
- CA
5
h-index
- TE
4
h-index
- BD
3
h-index
- PI
3
h-index
- RD
3
h-index
1–5 of 350
Institutions
119
Howard Hughes Medical Institute
Chevy Chase, United States
6 h-index
10 publications
4.6K citations
Duke University
Durham, United States
6 h-index
59 publications
30.4K citations
Duke Medical Center
Durham, United States
5 h-index
23 publications
8.4K citations
Stanford University
Stanford, United States
5 h-index
36 publications
7.6K citations
University of Utah
Salt Lake City, United States
3 h-index
16 publications
1.1K citations
Duke University Hospital
Durham, United States
3 h-index
12 publications
1.3K citations
Chan Zuckerberg Initiative (United States)
Redwood City, United States
3 h-index
5 publications
2.6K citations
The University of Tokyo
Tokyo, Japan
2 h-index
4 publications
143 citations
1–8 of 119
Venues
- Nucleic Acids Research
4 publications · 980 citations
4
h-index
- Cell
3 publications · 1.5K citations
3
h-index
- Nature Methods
3 publications · 1.2K citations
3
h-index
- Nature Biotechnology
3 publications · 2.6K citations
3
h-index
- PubMed
Repository · 2 publications · 78 citations
2
h-index
1–5